Published in Br Med J (Clin Res Ed) on June 01, 1985
Nebulisers: uses and abuses. Arch Dis Child (1986) 1.41
Home nebulisers in childhood asthma: survey of hospital supervised use. BMJ (1991) 1.39
Use of anti-asthma drugs in New Zealand. Thorax (1987) 0.97
A national survey of nebuliser use. Arch Dis Child (1991) 0.92
Cardiac arrhythmias during acute exacerbations of chronic airflow limitation: effect of fall in plasma potassium concentration induced by nebulised beta 2-agonist therapy. Postgrad Med J (1989) 0.77
The peak flow whistle: a simple device for monitoring peak flow in children. Br Med J (Clin Res Ed) (1986) 0.75
Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet (1969) 12.03
Mortality from asthma: a new epidemic in New Zealand. Br Med J (Clin Res Ed) (1982) 6.78
Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J (Clin Res Ed) (1984) 4.46
Deposition of pressurised aerosols in the human respiratory tract. Thorax (1981) 3.73
Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J (1979) 3.18
Asthma in New Zealand. Br Med J (Clin Res Ed) (1983) 2.63
Physician knowledge in the use of canister nebulizers. Chest (1983) 1.47
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (1999) 3.22
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem (1999) 2.33
Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever. Br J Clin Pharmacol (1978) 1.55
Uncomplicated HL-A matched sibling bone marrow graft for combined immune deficiency. Br Med J (1972) 1.49
Asbestos pleural disease. Br J Dis Chest (1982) 1.48
A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors. J Biol Chem (1987) 1.47
The value of performing head CT in screening for cerebral metastases in patients with potentially resectable non-small cell lung cancer: experience from a UK cardiothoracic centre. Clin Radiol (2004) 1.42
Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunology (1985) 1.40
Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy. Curr Cancer Drug Targets (2009) 1.32
Regulation of monocyte integrin expression by beta-family chemokines. J Immunol (1994) 1.30
Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology (2005) 1.26
Identification of soluble interleukin-1 binding protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor. J Biol Chem (1990) 1.25
Comparison of two different mouthpieces for the measurement of Pimax and Pemax in normal and weak subjects. Eur Respir J (1988) 1.15
Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax (2005) 1.13
The fate of pro-TNF-alpha following inhibition of metalloprotease-dependent processing to soluble TNF-alpha in human monocytes. J Immunol (1997) 1.13
High-dose corticosteroids in severe acute asthma. Br Med J (1976) 1.12
Modification of tumor necrosis factor-alpha (TNF-alpha) production by the Na(+)-dependent HCO3- cotransport in lipopolysaccharide-activated human monocytes. Immunopharmacology (1995) 1.11
Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol (1992) 1.08
Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. J Immunol (1999) 1.03
Identification of IL-1 receptors on human monocytes. J Immunol (1989) 1.02
The measurement of inspiratory muscle strength by sniff esophageal, nasopharyngeal, and mouth pressures. Am Rev Respir Dis (1989) 1.02
Human monocyte production of interleukin-1: parameters of the induction of interleukin-1 secretion by lipopolysaccharides. J Leukoc Biol (1986) 1.00
Effect of lung cancer surgery on quality of life. Thorax (2005) 0.97
Permuteins of interleukin 1 beta--a simplified approach for the construction of permutated proteins having new termini. Protein Eng (1992) 0.96
Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma. Clin Endocrinol (Oxf) (1985) 0.96
The Charing Cross Hospital Child Development Centre: a description of its work ad an evaluation of its first 385 patients. Child Care Health Dev (1978) 0.96
Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J (2005) 0.95
Role of glucose in interleukin-1 beta production by lipopolysaccharide-activated human monocytes. J Cell Physiol (1993) 0.92
2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis. J Med Chem (1993) 0.92
Evaluation of two spirometers: a comparative study of the Stead-Wells and the vitalograph spirometers. Chest (1976) 0.91
A survey of patients diagnosed as having asbestosis. Med Sci Law (1976) 0.90
Scarring alopecia. Dermatol Clin (1987) 0.90
Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo. J Med Chem (2001) 0.89
High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta. Mol Biol Med (1987) 0.89
Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family. J Leukoc Biol (1994) 0.89
Do Not Attempt Cardiopulmonary Resuscitation orders in acute medical settings: a qualitative study. QJM (2012) 0.89
Pigmented purpuric eruptions. Dermatol Clin (1985) 0.88
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha. Proc Natl Acad Sci U S A (2001) 0.88
Aggrecanase. A target for the design of inhibitors of cartilage degradation. Ann N Y Acad Sci (1999) 0.88
Inspiratory muscle relaxation rate after voluntary maximal isocapnic ventilation in humans. J Appl Physiol (1985) (1991) 0.86
Kyphosis secondary to tuberculosis osteomyelitis as a cause of ventilatory failure. Clinical features, mechanisms, and management. Chest (1996) 0.85
A guide to compensation for asbestos-related diseases. Br Med J (Clin Res Ed) (1981) 0.85
Internalization and nuclear localization of interleukin 1 are not sufficient for function. Cell Growth Differ (1991) 0.85
Two doses of triprolidine for treatment of allergic rhinitis. Ann Allergy (1979) 0.85
A Case of Pulmonary Osteo-Arthropathy. Trans Am Climatol Assoc (1901) 0.84
Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity. J Exp Med (1988) 0.84
Quantitation of related proteins by Western blot analysis. J Immunol Methods (1988) 0.83
The effect of posture and abdominal binding on respiratory pressures. Eur Respir J (1989) 0.83
The thyroid. Dermatol Clin (1989) 0.82
Repigmentation of vitiliginous skin by cultured cells. Pigment Cell Res (1989) 0.81
Escherichia coli: derived murine interleukin-1 beta with N-terminus partially N alpha-acetylated. Protein Expr Purif (1993) 0.81
Angiolymphoid hyperplasia with eosinophilia. A case report and review of the literature. Arch Otolaryngol Head Neck Surg (1988) 0.81
Clinical evaluation of five spirometers. Monaghan M403, Pneumoscreen, Spirotron, Vicatest and Vitalograph. Eur J Respir Dis (1981) 0.81
Association of interleukin-1-induced, NF kappa B DNA-binding activity with collagenase gene expression in human gingival fibroblasts. Arch Oral Biol (1996) 0.80
Type I interleukin-1 receptors in the mouse brain-endocrine-immune axis labelled with [125I]recombinant human interleukin-1 receptor antagonist. J Neuroimmunol (1992) 0.80
Muteins of human interleukin-1 that show enhanced bioactivities. FEBS Lett (1987) 0.80
The need for a do-not-resuscitate policy in a public city hospital. J Natl Med Assoc (1988) 0.79
Species differences in [125I]interleukin-1 binding in brain, endocrine and immune tissues. Brain Res (1993) 0.79
Discrimination between nonmalignant and malignant cells by combinations of IFN-gamma and IFN-alpha/beta. J Biol Response Mod (1984) 0.79
Some Observations which Appear to Establish the Aërial Transportation of Malarial Germs. Trans Am Climatol Assoc (1895) 0.79
The total chemical synthesis of monocyte chemotactic protein-1 (MCP-1). J Pept Sci (1997) 0.78
Hypothalamo-pituitary-adrenal function in intrinsic non-atopic asthma. Thorax (1975) 0.78
Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation. Agents Actions (1987) 0.78
The immune response of allophenic mice to 2,4-dinitrophenyl (DNP)-bovine gamma globulin. I. Allotype analysis of anti-DNP antibody. J Exp Med (1978) 0.78
Serial pulmonary function tests in patients with asbestosis. Thorax (1977) 0.77
Clinical trials in lung cancer: evidence that a programmed investigation unit and a multidisciplinary clinic may improve recruitment. Clin Oncol (R Coll Radiol) (2001) 0.77
Characterization of murine IL-1 beta. Isolation, expression, and purification. J Immunol (1988) 0.77
Human N-terminal analogs of interleukin 1 beta demonstrate altered binding and function in hematopoiesis. Exp Hematol (1990) 0.77
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonists. Bioorg Med Chem (1994) 0.76
A surgical treatment for vitiligo: autologous cultured-epithelial grafts. J Dermatol Surg Oncol (1989) 0.76
Coeliac syndrome. Proc R Soc Med (1968) 0.76
Necrotizing Enteritis Following Myomectomy. Proc R Soc Med (1965) 0.75
Diaphragmatic paresis: pathophysiology, clinical features, and investigation. Thorax (1990) 0.75
Second-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubility. J Med Chem (1994) 0.75
General physician and specialist training in thoracic medicine. Br Med J (1976) 0.75
Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus. Arch Dermatol (1986) 0.75
Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin. Thorax (1988) 0.75
A Sketch of the Origin of Auscultation and Percussion and of the State of Clinical Medicine in the time of Auenbrugger and Laënnec. Trans Am Climatol Clin Assoc (1914) 0.75
A comparison of the bronchodilator action of pseudoephedrine and ephedrine in patients with reversible airway obstruction. Eur J Clin Pharmacol (1982) 0.75
Effects of intracellular ions on interleukin-1 beta production by lipopolysaccharide-activated human monocytes. Am J Physiol (1992) 0.75
Asthma in merchant seamen and laboratory workers caused by allergy to castor beans: analysis of allergens. Clin Allergy (1983) 0.75
Modulation of synovial fibroblast plasminogen activator and plasminogen activator inhibitor production by protein kinase C. Biochim Biophys Acta (1991) 0.75
Fenoterol solution via nebuliser--optimum dosage. Eur J Respir Dis (1987) 0.75
Heightened cutaneous reactions to mosquito bites in patients with acquired immunodeficiency syndrome receiving zidovudine. Arch Intern Med (1988) 0.75
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists. Bioorg Med Chem Lett (2001) 0.75
Some of the Rules for the Treatment of Consumption laid down by Sydenham and his Successors. Trans Am Climatol Assoc (1911) 0.75
Giant Mycobacterium fortuitum abscess associated with systemic lupus erythematosus. Arch Dermatol (1986) 0.75
Hygiene in the Prophylaxis and Treatment of Consumption. Trans Am Climatol Assoc (1907) 0.75
Dampness as a Factor in Tuberculosis. Trans Am Climatol Assoc (1900) 0.75
Traumatic Ruptures of the Heart, with a Case. Trans Am Climatol Assoc (1899) 0.75
Phenylacetamides as selective alpha-1A adrenergic receptor antagonists. Bioorg Med Chem Lett (2000) 0.75
Systemic interleukin I administration suppresses arachidonic acid-induced ear oedema in the mouse. Br J Dermatol (1989) 0.75
A Preliminary Report upon some Ambulatory Cases of Tuberculosis, Treated by Tuberculin. Trans Am Climatol Clin Assoc (1917) 0.75
Left atrial tumour mimicking pulmonary embolism. Respir Med (1997) 0.75
A clinical trial of topical terbinafine (a new allylamine antifungal) in the treatment of tinea pedis. J Am Acad Dermatol (1990) 0.75
The diaphragm in SLE. Chest (1988) 0.75
Studies in Deep Breathing. Trans Am Climatol Assoc (1903) 0.75
Some Personal Observations upon the Effects of Changes of Climate upon Men and Animals. Trans Am Climatol Assoc (1897) 0.75